Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Annexin A2 antibodies in post-treatment Lyme disease

Therapeutic Advances in Infectious Disease(2024)10.1177/20499361241242971Source: DataRank Database

Annexin A2 antibodies in post-treatment Lyme disease is a research paper published in Therapeutic Advances in Infectious Disease (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.16)OA: goldTopics (18)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Alison W. Rebman ORCID,Marcia Daniela Villegas de Flores,Hong Wang ORCID,Erika Darrah ORCID,John N. Aucott ORCID

Live enrichment

PubMed:38559699 PMC:PMC10981857 OpenAlex:https://openalex.org/W4393347479

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: P30 AR070254

National Institutes of Health

Grant: 1P30AR070254-01

Johns Hopkins Rheumatic Diseases Resource-based Core Center

Rheumatology Research Foundation Career Development Funding Award: K Bridge

Jerome L. Greene Foundation

FWCI

0.16

Citation Percentile

0.5%

Citation Trend

2024

goldLicense: cc-by-nc

journalhttps://doi.org/10.1177/20499361241242971

publisherhttps://doi.org/10.1177/20499361241242971

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/20499361241242971

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/20499361241242971

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38559699

Fields of Study

S100 Proteins and AnnexinsImmune Response and InflammationIntracerebral and Subarachnoid Hemorrhage Research0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

MedicineInternal medicineAntibodyGastroenterologyLyme diseaseDermatologyImmunologyAutoantibodiesAnti-annexin A2Brief ReportInfectious and parasitic diseasesRC109-216

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

sj-docx-2-tai-10.1177_20499361241242971 – Supplemental material for Annexin A2 antibodies in post-treatment Lyme disease

10.25384/sage.25514321SAGE Journals

sj-docx-1-tai-10.1177_20499361241242971 – Supplemental material for Annexin A2 antibodies in post-treatment Lyme disease

10.25384/sage.25514318SAGE Journals

sj-docx-2-tai-10.1177_20499361241242971 – Supplemental material for Annexin A2 antibodies in post-treatment Lyme disease

10.25384/sage.25514321.v1SAGE Journals

sj-docx-1-tai-10.1177_20499361241242971 – Supplemental material for Annexin A2 antibodies in post-treatment Lyme disease

10.25384/sage.25514318.v1SAGE Journals